Rare diseases
Investigational molecules
Locations
2032 North Clybourn Avenue Suite 100, 60614-4051, United States
Clinical research in pulmonary sarcoidosis with or without extrapulmonary manifestations is a major focus, with attention to respiratory involvement and broader inflammatory burden.
Work in this area centers on treatment options for patients with persistent disease activity and associated organ involvement.
Xentria Inc. runs clinical trials in conditions such as Sarcoidosis, Osteoporosis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study on Long-term Safety of XTMAB-16 for Patients with Pulmonary Sarcoidosis with or without Extra-pulmonary Involvement
CzechiaStudy of XTMAB-16 and Prednisolone Sodium Phosphate for Patients with Pulmonary Sarcoidosis
CzechiaStudy on the Effects of XTMAB-16 and Prednisolone in Patients with Pulmonary Sarcoidosis with or without Other Body Involvement
CzechiaStudy Comparing MAB-22 and Denosumab for Treating Osteoporosis in Postmenopausal Women
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
